AtriCure (ATRC) Insider Trading & Ownership $31.78 +0.39 (+1.24%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AtriCure (NASDAQ:ATRC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$400.38K Get ATRC Insider Trade Alerts Want to know when executives and insiders are buying or selling AtriCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATRC Insider Buying and Selling by Quarter AtriCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/28/2025Vinayak DoraiswamyInsiderSell2,500$33.44$83,600.00 3/5/2025Karen PrangeDirectorSell6,100$38.12$232,532.00 8/15/2024Maggie YuenDirectorSell3,500$24.07$84,245.00 (Data available from 1/1/2013 forward) ATRC Insider Trading Activity - Frequently Asked Questions Who is on AtriCure's Insider Roster? The list of insiders at AtriCure includes Justin J Noznesky, Karen Prange, Karl S Dahlquist, Maggie Yuen, Salvatore Privitera, and Vinayak Doraiswamy. Learn more on insiders at ATRC. What percentage of AtriCure stock is owned by insiders? 3.50% of AtriCure stock is owned by insiders. Learn more on ATRC's insider holdings. Which AtriCure insiders have been buying company stock? The following insider purchased ATRC shares in the last 24 months: Salvatore Privitera ($111,250.00). How much insider buying is happening at AtriCure? Insiders have purchased a total of 5,000 ATRC shares in the last 24 months for a total of $111,250.00 bought. Which AtriCure insiders have been selling company stock? The following insiders have sold ATRC shares in the last 24 months: Justin J Noznesky ($136,800.00), Karen Prange ($232,532.00), Karl S Dahlquist ($606,176.93), Maggie Yuen ($84,245.00), and Vinayak Doraiswamy ($83,600.00). How much insider selling is happening at AtriCure? Insiders have sold a total of 31,381 AtriCure shares in the last 24 months for a total of $1,143,353.93 sold. Which members of congress are trading AtriCure? Josh Gottheimer (D-NJ) has bought shares of AtriCure in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies TFX Insider Trading ITGR Insider Trading ATEC Insider Trading IART Insider Trading SRDX Insider Trading ANGO Insider Trading OFIX Insider Trading ARAY Insider Trading RMTI Insider Trading RSLS Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:ATRC) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
